U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050485) titled 'Postbiotics for Mitigation of Postoperative Dysbiosis in Colon Cancer Surgery' on June 20.
Brief Summary: To measure the efficacy of postbiotic supplements in mitigating the gut dysbiosis induced by colon cancer surgery. Efficacy in mitigating dysbiosis will be measured by the change in fecal Shannon Diversity Index (SDI) within patients from the baseline sample to various postoperative timepoints. Mean change in SDI from baseline will be compared between groups at 2 weeks postoperative
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Colon Cancer
Intervention:
DIETARY_SUPPLEMENT: PoZibio
1 gummy once daily
DIE...